Scinai Immunotherapeutics (SCNI) Other Non Operating Income (2014 - 2024)

Scinai Immunotherapeutics' (SCNI) quarterly Other Non Operating Income came in at $16.1 million in Q4 2024, up 535.85% year-on-year from $2.5 million in Q1 2024, and up 956.9% quarter-over-quarter from -$1.9 million in Q3 2024.

Scinai Immunotherapeutics (SCNI) Other Non Operating Income (2014 - 2024) Analysis & Trends

Scinai Immunotherapeutics has disclosed Other Non Operating Income across 4 years of filings, most recently posting $16.1 million for Q4 2024.

  • Other Non Operating Income for Q4 2024 came in at $16.1 million, up 535.85% year-over-year; the trailing twelve-month figure through Dec 2024 was $13.7 million (up 285.17% YoY), and the FY2024 annual result was $14.8 million, up 163888.89% from the prior year.
  • Other Non Operating Income came in at $16.1 million for Q4 2024 at Scinai Immunotherapeutics, up from -$1.9 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $16.1 million in Q4 2024 to a low of -$5.2 million in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Scinai Immunotherapeutics 3.02 Bn 988.23 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 16.14 Mn
Sep 30, 2024 -1.88 Mn
Jun 30, 2024 -757,000.00
Mar 31, 2024 231,000.00
Dec 31, 2023 -3.70 Mn
Sep 30, 2023 -5.21 Mn
Jun 30, 2023 1.17 Mn
Mar 31, 2023 329,000.00
Sep 30, 2015 -2.35 Mn
Dec 31, 2014 -206,000.00
Sep 30, 2014 -160,000.00